Affiliation:
1. Department of Pharmaceutial Sciences, Guru Gobind Singh College of Pharmacy, Yamuna Nagar, Haryana, India
2. Department of Pharmaceutics Sciences, CT Institute of Pharmaceutical Sciences, Shahpur Campus, Jalandhar (Pb.), India
Abstract
Background:
The evolution of COVID-19 vaccinations, which are mostly seen as crucial
to curb the epidemic, is a result of remarkable and ground-breaking researches by scientists
around the world.
Objective:
The main goal of this study was to identify the significant adverse reactions of these
vaccines, specifically in Homo sapiens.
Methods:
In this research, a trial version of Qualtrics CoreXM software was used, and 18 questionnaires
were prototyped as part of an online survey that was done in the northern part of India.
Results:
The dataset included survey responses from 286 vaccinated (Corbevax) respondents' samples
detailing their demographics, daily activities, type of gastronomic preferences, and any prior
illnesses. The data were collected between March 24, 2022, and April 26, 2022. After analysis,
70.98% of respondents who took the first dose of the medication experienced side effects, while
50.62% of respondents who took the second dose of the medication stated the same. The major
side effects reported were injection site pain, fever, tiredness, body ache, headache, etc.
Conclusion:
After conducting a poll on children (aged 12-18) who had received the COVID-19 vaccination,
we concluded that immunizations rarely cause moderate side effects that are manageable.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Pharmacology,Toxicology